HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.

Abstract
The apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape-1/Ref-1) is a multi-functional protein, involved in DNA repair and the activation of redox-sensitive transcription factors. The Ape-1/Ref-1 redox domain acts as a cytoprotective element in normal endothelial cells, mitigating the deleterious effects of apoptotic stimuli through induction of survival signals. We explored the role of the Ape-1/Ref-1 redox domain in the maintenance of tumor-associated endothelium, and of endothelial progenitor cells (EPCs), which contribute to tumor angiogenesis. We demonstrate that E3330, a small molecule inhibitor of the Ape-1/Ref-1 redox domain, blocks the in vitro growth of pancreatic cancer-associated endothelial cells (PCECs) and EPCs, which is recapitulated by stable expression of a dominant-negative redox domain mutant. Further, E3330 blocks the differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) into CD31(+) endothelial progeny. Exposure of PCECs to E3330 results in a reduction of H-ras expression and intracellular nitric oxide (NO) levels, as well as decreased DNA-binding activity of the hypoxia-inducible transcription factor, HIF-1alpha. E3330 also reduces secreted and intracellular vascular endothelial growth factor expression by pancreatic cancer cells, while concomitantly downregulating the cognate receptor Flk-1/KDR on PCECs. Inhibition of the Ape-1/Ref-1 redox domain with E3330 or comparable angiogenesis inhibitors might be a potent therapeutic strategy in solid tumors.
AuthorsGang-Ming Zou, Collins Karikari, Yasuaki Kabe, Hiroshi Handa, Robert A Anders, Anirban Maitra
JournalJournal of cellular physiology (J Cell Physiol) Vol. 219 Issue 1 Pg. 209-18 (Apr 2009) ISSN: 1097-4652 [Electronic] United States
PMID19097035 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2008 Wiley-Liss, Inc.
Chemical References
  • Benzoquinones
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Propionates
  • Vascular Endothelial Growth Factor A
  • E 3330
  • Nitric Oxide
  • Vascular Endothelial Growth Factor Receptor-2
  • APEX1 protein, human
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
Topics
  • Animals
  • Benzoquinones (metabolism)
  • Cell Differentiation
  • Cell Lineage
  • Cells, Cultured
  • DNA-(Apurinic or Apyrimidinic Site) Lyase (antagonists & inhibitors, genetics, metabolism)
  • Endothelial Cells (cytology, physiology)
  • Endothelium (cytology, physiology)
  • Homeostasis
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms (drug therapy, pathology, physiopathology)
  • Neovascularization, Pathologic
  • Nitric Oxide (metabolism)
  • Oxidation-Reduction
  • Pancreatic Neoplasms (drug therapy, pathology, physiopathology)
  • Propionates (metabolism)
  • Stem Cells (cytology, physiology)
  • Transplantation, Heterologous
  • Vascular Endothelial Growth Factor A (metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: